Bacterial respiratory infections compounded with antibiotic-resistant infection strains quickly deteriorate patient outcomes. Renuvix Labs utilizes the RT-PCR protocol to rapidly assess and provide appropriate antibiotic recommendations to all respiratory infections. Our highly specific assays express 99% specificity of the most relevant bacterial, viral, and fungal vectors, including Influenza, COVID-19, Haemophilus influenza, Streptococcus pneumoniae and Staphylococcus aureus.